Ad is loading...
PAADX
Price
$17.56
Change
-$0.16 (-0.90%)
Updated
Nov 15 closing price
RLEFX
Price
$36.11
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

PAADX vs RLEFX

Header iconPAADX vs RLEFX Comparison
Open Charts PAADX vs RLEFXBanner chart's image
Putnam Dynamic Asset Allocation Bal R5
Price$17.56
Change-$0.16 (-0.90%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R5E
Price$36.11
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
PAADX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PAADX vs. RLEFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAADX is a StrongSell and RLEFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 236B vs. PAADX (2.11B). RLEFX pays higher dividends than PAADX: RLEFX (2.42) vs PAADX (1.82). PAADX was incepted earlier than RLEFX: PAADX (12 years) vs RLEFX (9 years). PAADX is a more actively managed with annual turnover of: 302.00 vs. RLEFX (171.00). PAADX has a lower initial minimum investment than RLEFX: PAADX (0) vs RLEFX (250). PAADX (21.61) and RLEFX (21.09) have marching annual gain over last year. RLEFX return over 5 years is better than : 35.95 vs. PAADX (27.91).
PAADXRLEFXPAADX / RLEFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD16.14814.211114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.11B236B1%
Annual Yield % from dividends1.822.4275%
Returns for 1 year21.6121.09102%
Returns for 3 years-1.5910.95-14%
Returns for 5 years27.9135.9578%
Returns for 10 years35.49N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SKYW111.330.52
+0.47%
SkyWest
TCBK47.59-0.02
-0.04%
TriCo Bancshares
WIT6.72-0.07
-1.03%
Wipro Limited
EDAP2.45-0.07
-2.78%
EDAP TMS SA
ELEV0.53-0.05
-8.41%
Elevation Oncology